artesunic acid has been researched along with HPV Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| AlHilli, M; Beffa, L; Belinson, JL; Brainard, J; Debernardo, R; Michener, CM; Plesa, M; Ricci, S; Trimble, CL; Waggoner, SE | 1 |
| Clark, KT; Donovan, MJ; Frantz, PS; Fu, J; Levinson, K; Maldonado, L; Plesa, M; Sanders, SA; Sauter, ME; Shay, ME; Trimble, CL | 1 |
1 trial(s) available for artesunic acid and HPV Infection
| Article | Year |
|---|---|
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
Topics: Administration, Intravaginal; Adult; Antineoplastic Agents; Artesunate; Dose-Response Relationship, Drug; Female; Humans; Papillomaviridae; Papillomavirus Infections; Proof of Concept Study; Self Administration; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2020 |
1 other study(ies) available for artesunic acid and HPV Infection
| Article | Year |
|---|---|
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3.
Topics: Artesunate; Biopsy; Carcinoma in Situ; Female; Humans; Neoplasms; Papillomavirus Infections; Prospective Studies; Vulvar Neoplasms | 2023 |